Skip to main content

Table 4 Fazekas grade and score of leukoencephalopathies

From: Therapeutic effect of osimertinib plus cranial radiotherapy compared to osimertinib alone in NSCLC patients with EGFR-activating mutations and brain metastases: a retrospective study